Merrimack
is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read moreMerrimack
is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
News
May 15, 2024
Marketscreener
Merrimack: Merrimack Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May 10, 2024
BioSpace
Merrimack: Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Mar 27, 2024
StreetInsider
Merrimack Pharmaceuticals Inc: Merrimack Receives $225 Million Milestone Payment from Ipsen
Mar 08, 2024
Owler
Merrimack Pharmaceuticals Inc: Merrimack Pharmaceuticals Inc's employee count had no change from Dec 2020 to Dec 2023
Mar 07, 2024
MarketScreener
Merrimack Pharmaceuticals Inc: Merrimack Reports Full Year 2023 Financial Results
Feb 13, 2024
StreetInsider
Press Release: Merrimack Pharmaceuticals Inc : Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Met
Feb 13, 2024
MarketScreener
Merrimack Pharmaceuticals Inc: Merrimack Pharmaceuticals to Get $225 Million Milestone Payment After FDA's Supplemental NDA Approval
Nov 02, 2023
MarketScreener
Merrimack Pharmaceuticals Inc: Merrimack Reports Third Quarter 2023 Financial Results
Aug 04, 2023
MarketScreener
Merrimack Pharmaceuticals Inc: Merrimack Reports Second Quarter 2023 Financial Results
Aug 03, 2023
Benzinga
Merrimack Pharmaceuticals Inc: Merrimack Pharmaceuticals Q2 EPS $(0.03) Up From $(0.04) YoY
Merrimack Competitors
1
2
3
4
5
6
7
8
9
10